Malignant Small Intestinal Neoplasm

Observed

→ investigated in trials for

Gemcitabinesmall molecule

13 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

12 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

12 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fluorouracilsmall molecule

10 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rituximabmonoclonal antibody

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall molecule

9 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

9 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall molecule

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Malignant Duodenal Neoplasm

Malignant Small Intestinal Neoplasm studied in …STUDIED_INderived10 of 279show all (up to 200)
→ studied in	NCT07845617recruiting Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma · condition mapped ALIAS · 279 trials mapped (59 active)	—	—	Malignant Duodenal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT03623464NA · suspended RCT of Mobile Apps & FitBit v. Usual Care · condition mapped ALIAS · 279 trials mapped (59 active)	—	—	Small Intestinal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07844057Phase 2 · not yet recruiting First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma · condition mapped ALIAS · 279 trials mapped (59 active)	—	—	Small Intestinal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07060014Phase 1 · recruiting NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers · condition mapped CURATED_BROADER · 279 trials mapped (59 active)	—	—	Small Intestinal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02381561Phase 1 · active not recruiting Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 279 trials mapped (59 active)	—	—	Malignant Small Intestinal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04111172Phase 2 · suspended A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 279 trials mapped (59 active)	—	—	Small Intestinal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07081360Phase 3 · recruiting Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer · condition mapped ALIAS · 279 trials mapped (59 active)	—	—	Periampullary Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07132541Phase 1 · recruiting Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate) · condition mapped ALIAS · 279 trials mapped (59 active)	—	—	Periampullary Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07780838Phase 2 · recruiting Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma · condition mapped CURATED_BROADER · 279 trials mapped (59 active)	—	—	Ampulla of Vater Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ONTOLOGY_EXACT · 279 trials mapped (59 active)	—	—	Duodenal Adenocarcinoma	1	Observed	clinicaltrials	graph →

Malignant Small Intestinal Neoplasm studied in …STUDIED_INderived10 of 279show all (up to 200)

→ studied in

NCT07845617recruiting

Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma · condition mapped ALIAS · 279 trials mapped (59 active)

—

Observed

Small Intestinal Carcinoma

→ studied in

NCT03623464NA · suspended

RCT of Mobile Apps & FitBit v. Usual Care · condition mapped ALIAS · 279 trials mapped (59 active)

—

Observed

Small Intestinal Adenocarcinoma

→ studied in

NCT07844057Phase 2 · not yet recruiting

First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma · condition mapped ALIAS · 279 trials mapped (59 active)

—

Observed

Small Intestinal Carcinoma

→ studied in

NCT07060014Phase 1 · recruiting

NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers · condition mapped CURATED_BROADER · 279 trials mapped (59 active)

—

Observed

→ studied in

NCT02381561Phase 1 · active not recruiting

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 279 trials mapped (59 active)

—

Observed

Small Intestinal Adenocarcinoma

→ studied in

NCT04111172Phase 2 · suspended

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 279 trials mapped (59 active)

—

Observed

Periampullary Adenocarcinoma

→ studied in

NCT07081360Phase 3 · recruiting

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer · condition mapped ALIAS · 279 trials mapped (59 active)

—

Observed

Periampullary Adenocarcinoma

→ studied in

NCT07132541Phase 1 · recruiting

Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate) · condition mapped ALIAS · 279 trials mapped (59 active)

—

Observed

Ampulla of Vater Carcinoma

→ studied in

NCT07780838Phase 2 · recruiting

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma · condition mapped CURATED_BROADER · 279 trials mapped (59 active)

—

Observed

→ studied in

NCT07282912Phase 2 · recruiting

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ONTOLOGY_EXACT · 279 trials mapped (59 active)

—

Duodenal Adenocarcinoma

Observed